Form 8-K - Current report:
SEC Accession No. 0000950170-25-044801
Filing Date
2025-03-26
Accepted
2025-03-26 08:05:08
Documents
14
Period of Report
2025-03-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onvo-20250321.htm   iXBRL 8-K 49204
2 EX-99.1 onvo-ex99_1.htm EX-99.1 9997
3 GRAPHIC img73928077_0.gif GRAPHIC 43
4 GRAPHIC img73928077_1.jpg GRAPHIC 7360
  Complete submission text file 0000950170-25-044801.txt   187582

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onvo-20250321.xsd EX-101.SCH 24862
16 EXTRACTED XBRL INSTANCE DOCUMENT onvo-20250321_htm.xml XML 4706
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35996 | Film No.: 25770235
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)